ID   ICC-2
AC   CVCL_C6N4
DR   Wikidata; Q116049559
RX   PubMed=29913454;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
RX   PubMed=29913454; DOI=10.1159/000490210;
RA   Yu, Guang-Yang
RA   Wang, Xuan
RA   Zheng, Su-Su
RA   Gao, Xiao-Mei
RA   Jia, Qing-An
RA   Zhu, Wen-Wei
RA   Lu, Lu
RA   Jia, Hu-Liang
RA   Chen, Jin-Hong
RA   Dong, Qiong-Zhu
RA   Lu, Ming
RA   Qin, Lun-Xiu
RT   "RA190, a proteasome subunit ADRM1 inhibitor, suppresses intrahepatic
RT   cholangiocarcinoma by inducing NF-KB-mediated cell apoptosis.";
RL   Cell. Physiol. Biochem. 47:1152-1166(2018).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan, Abdulkadir
RA   Yenigun, Ali
RA   Soma, Daiki
RA   Aksu, Eric
RA   Lopez, Kevin
RA   Park, Yujin
RA   Cross-Najafi, Arthur
RA   Li, Ping
RA   Kundu, Debjyoti
RA   House, Michael G.
RA   Chakraborty, Sanjukta
RA   Glaser, Shannon
RA   Kennedy, Lindsey
RA   Francis, Heather
RA   Zhang, Wen-Jun
RA   Alpini, Gianfranco D.
RA   Ekser, Burcin
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//